The new capital will be used to expand Sugar.fit's technology stack and product range, increase brand presence, and speed up research and development in diabetes management.
Sugar.fit, a health-tech start-up focused on addressing Type 2 diabetes and prediabetes with a comprehensive, evidence-based, and data-centric approach, has secured an extra $5 million in Series A funding. This brings the total Series A funding to $16 million.
B Capital led the recent funding, with previous participation from MassMutual Ventures and existing investors including Tanglin Venture Partners, Endiya Partners, and Cure.Fit.
The new capital will be used to expand Sugar.fit's technology stack and product range, increase brand presence, and speed up research and development in diabetes management.
Diabetes is increasing worldwide, particularly in India, where 101 million people, that is 11 per cent of the country's population has diabetes. As a major cause of life-threatening health complications, there is an urgent need for effective interventions and advanced management solutions, as per the company statement.
The company has also established an omnichannel presence, starting in Bangalore, and now operates seven state-of-the-art diabetes clinics with top doctors in diabetes care across the city. These clinics aim to enhance the brand's visibility while offering a range of innovative wellness therapies for stress management, live fitness and yoga sessions, VR chromotherapy, and more.
Madan Somasundaram, co-founder and CEO of Sugar.fit, said, "Health habits of consumers have changed over the past few years, and the need for a new tech-driven approach is paramount for sustainable health outcomes. Sugar.fit has created a unique platform to help meet this demand and to become the go-to destination for all diabetes needs in India.”
Founded at the end of 2021, Sugar.fit witnessed significant growth in paid subscribers, currently serving more than 30,000 users on its platform, as per a company statement.